| 2025-02-05 |
复牌提示：
2025-02-04 19:50:00 停牌，复牌日期 2025-02-06 00:00:01
|
| 2025-01-27 |
详情>>
内部人交易：
Hancock Richard B股份减少20128.00股
|
| 2024-12-18 |
股东大会：
将于2025-01-30召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated November 6, 2024, (such agreement, as it may be amended, modified or supplemented from time to time, the “Merger Agreement”), by and among Avid, Space Finco, Inc., a Delaware corporation (“Parent”), and Space Mergerco, Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”) and approve the Merger (as defined below) (the “Merger Agreement Proposal”). Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into Avid, and as a result of which the separate existence of Merger Sub will cease, and Avid will continue as the surviving corporation and a wholly owned subsidiary of Parent (the “Merger”);
2.To consider and vote on the proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the “Compensation Proposal”);
3.To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the Merger Agreement Proposal if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2024-12-10 |
详情>>
股本变动：
变动后总股本6396.33万股
|
| 2024-12-10 |
详情>>
业绩披露：
2025年中报每股收益-0.36美元,归母净利润-2294万美元,同比去年增长-97.03%
|
| 2024-09-09 |
详情>>
业绩披露：
2025年一季报每股收益-0.09美元,归母净利润-553.4万美元,同比去年增长-160.79%
|
| 2024-09-09 |
财报披露：
美东时间 2024-09-09 盘后发布财报
|
| 2024-08-28 |
股东大会：
将于2024-10-16召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our Board of Directors until our 2025 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2025;
3.To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the accompanying Proxy Statement under “Compensation Discussion and Analysis” and “Executive Compensation”;
4.To approve an amendment to our 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder;
5.To approve an amendment to our 2010 Employee Stock Purchase Plan, which we refer to as the “ESPP”, to remove the expiration date so that the ESPP does not expire;
6.To conduct any other business properly brought before the 2024 annual meeting and any adjournment or postponement thereof.
|
| 2024-07-02 |
详情>>
业绩披露：
2024年年报每股收益-2.23美元,归母净利润-1.41亿美元,同比去年增长-54444.79%
|
| 2024-07-02 |
详情>>
业绩披露：
2022年年报每股收益2.08美元,归母净利润1.28亿美元,同比去年增长3747.86%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年中报每股收益-0.18美元,归母净利润-1164.3万美元,同比去年增长-2953.68%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.28美元,归母净利润-1764.9万美元,同比去年增长-2130.96%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年一季报每股收益-0.03美元,归母净利润-212.2万美元,同比去年增长-255.91%
|
| 2024-04-24 |
详情>>
业绩披露：
2023年一季报每股收益0.02美元,归母净利润136.10万美元,同比去年增长-78.41%
|
| 2024-04-24 |
详情>>
业绩披露：
2023年年报每股收益0.00美元,归母净利润25.90万美元,同比去年增长-99.8%
|
| 2023-08-28 |
股东大会：
将于2023-10-23召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our Board of Directors until our 2024 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2024;
3.To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in this Proxy Statement under “Compensation Discussion and Analysis” and “Executive Compensation”;
4.To approve, by an advisory vote, the frequency of holding future advisory votes on the compensation of our named executive officers;
5.To conduct any other business properly brought before the Annual Meeting and any adjournment or postponement thereof.
|
| 2023-03-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.01美元,归母净利润86.90万美元,同比去年增长-92.8%
|
| 2022-12-06 |
详情>>
业绩披露：
2023年中报每股收益0.01美元,归母净利润40.80万美元,同比去年增长-95.85%
|
| 2022-08-29 |
股东大会：
将于2022-10-18召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our Board of Directors until our 2023 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2023;
3.To approve, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Compensation Discussion and Analysis” and “Executive Compensation”;
4.To approve an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company;
5.To conduct any other business properly brought before the 2022 annual meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-27 |
股东大会：
将于2021-10-21召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our Board of Directors until our 2022 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2022;
3.To approve, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Compensation Discussion and Analysis” and “Executive Compensation”:
4.To vote on an amendment to our 2018 Omnibus Incentive Plan to increase the shares reserved thereunder;
5.To conduct any other business properly brought before the 2021 annual meeting and any adjournment or postponement thereof.
|
| 2020-09-15 |
股东大会：
将于2020-10-20召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve on our Board of Directors until our 2021 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2021;
3.To approve, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Compensation Discussion and Analysis” and “Executive Compensation”;
4.To conduct any other business properly brought before the 2020 annual meeting and any adjournment or postponement thereof.
|
| 2019-08-21 |
股东大会：
将于2019-10-09召开股东大会
会议内容 ▼▲
- 1.To elect six directors to serve on our Board of Directors until our 2020 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2020;
3.To approve, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Executive Compensation”;
4.To approve an amendment to our 2010 Employee Stock Purchase Plan to extend its term for an additional five years to October 21, 2025 and make certain other changes as described in Proposal No. 4;
5.To conduct any other business properly brought before the 2019 annual meeting and any adjournment or postponement thereof.
|
| 2018-08-17 |
股东大会：
将于2018-10-04召开股东大会
会议内容 ▼▲
- (1)To elect seven directors to serve on our Board of Directors until our 2019 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
(2)To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2019;
(3)To approve, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Executive Compensation”;
(4)To approve an amendment to our Certificate of Incorporation, as amended (the “Charter”), to reduce the number of authorized shares of our common stock, $0.001 par value per share (“Common Stock”), from 500,000,000 to 150,000,000;
(5)To approve the Avid Bioservices, Inc. 2018 Omnibus Incentive Plan; (6)To conduct any other business properly brought before the 2018 Annual Meeting and any adjournment or postponement thereof.
|
| 2017-12-07 |
股东大会：
将于2018-01-18召开股东大会
会议内容 ▼▲
- (1)To elect seven directors to serve on our Board of Directors until our 2018 annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal;
(2)To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending April 30, 2018;
(3)To adopt, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Executive Compensation”;
(4)To vote, on an advisory basis, on the frequency of the advisory vote to approve the compensation of the Company’s named executive officers;
(5)To conduct any other business properly brought before the 2017 Annual Meeting and any adjournment or postponement thereof.
|
| 2017-07-07 |
详情>>
拆分方案：
每7.0000合并分成1.0000股
|
| 2016-08-26 |
股东大会：
将于2016-10-13召开股东大会
会议内容 ▼▲
- 1.To elect four directors to our Board of Directors to serve until the next annual meeting and until their successors are elected and qualified;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2017;
3.To approve an amendment to our certificate of incorporation, as amended, to effect a reverse stock split of the issued and outstanding shares of our common stock at a ratio to be established by our Board of Directors in its discretion, of up to 1-for-7, subject to the Board of Directors’ discretion to abandon such amendment;
4.To approve an amendment to our 2010 Employee Stock Purchase Plan;
5.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our Proxy Statement for the 2016 Annual Meeting of Stockholders;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2015-08-28 |
股东大会：
将于2015-10-15召开股东大会
会议内容 ▼▲
- 1.To elect four directors to our Board of Directors to serve until the next annual meeting and until their successors are elected and qualified;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2016;
3.To approve an amendment to our certificate of incorporation, as amended, to increase the number of shares of common stock authorized for issuance thereunder from 325 million to 500 million shares;
4.To approve an amendment to our 2011 Stock Incentive Plan;
5.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our Proxy Statement for the 2015 Annual Meeting of Stockholders;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|